BRIEF published on 09/29/2026 at 18:05, 8 days 17 hours ago THX Pharma publie ses résultats financiers pour le premier semestre 2026 Résultats Financiers Croissance Des Revenus Maladies Neurologiques THX Pharma Partenariat Biocodex
BRIEF published on 09/29/2026 at 18:05, 8 days 17 hours ago THX Pharma Releases Financial Results for H1 2026 Financial Results Revenue Growth Neurological Diseases THX Pharma Biocodex Partnership
BRIEF published on 09/29/2026 at 18:05, 8 days 17 hours ago THX Pharma Publishes its First Half 2026 Results Half-year Results Batten-1 Rare Neurological Diseases THX Pharma Biocodex Agreement
BRIEF published on 09/29/2026 at 18:05, 8 days 17 hours ago THX Pharma Publie ses Résultats du Premier Semestre 2026 Résultats Semestriels Batten-1 Maladies Neurologiques Rares THX Pharma Accord Biocodex
PRESS RELEASE published on 09/29/2026 at 18:00, 8 days 17 hours ago THX PHARMA REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 THX Pharma announces financial results for the six-month period ended June 30, 2026, showcasing revenue generation and strategic partnerships for rare neurological disease treatments Financial Results Clinical-Stage Biopharmaceutical Batten-1 Rare Neurological Diseases THX Pharma
PRESS RELEASE published on 09/29/2026 at 18:00, 8 days 17 hours ago THX PHARMA ANNONCE SES RESULTATS FINANCIERS DU PREMIER SEMESTRE 2026 THX Pharma publie ses résultats semestriels au 30 juin 2026, annonçant un chiffre d'affaires significatif, une trésorerie de 17,5M€ et des avancées dans les traitements des maladies neurologiques rares Chiffre D'affaires Résultats Semestriels Trésorerie Maladies Neurologiques Rares THX Pharma
BRIEF published on 09/09/2026 at 08:35, 29 days 2 hours ago Un Brevet Européen pour Batten-1 Renforce sa Protection Batten-1 Maladie De Batten Brevet Européen Miglustat Protection
BRIEF published on 09/09/2026 at 08:35, 29 days 2 hours ago European Patent Secures Batten-1's Future in Juvenile Batten Disease Treatment Orphan Drug Designation Batten-1 Juvenile Batten Disease European Patent THX Pharma
BRIEF published on 09/09/2026 at 08:35, 29 days 2 hours ago A European Patent for Batten-1 Strengthens its Protection Batten-1 Batten Disease European Patent Miglustat Protection
BRIEF published on 09/09/2026 at 08:35, 29 days 2 hours ago Un brevet européen garantit l'avenir du Batten-1 dans le traitement de la maladie de Batten juvénile. Désignation De Médicament Orphelin Batten-1 Brevet Européen THX Pharma Maladie De Batten Juvénile
Published on 10/08/2026 at 11:00, 30 minutes ago Silver Range Resources Ltd. Options Alamo and Sand Springs to Resilience Minerals Limited
Published on 10/08/2026 at 11:00, 30 minutes ago Meta Critical Minerals Initiates Maiden Drill Program At Table Mountain High-Purity Silica Project, British Columbia
Published on 10/07/2026 at 23:30, 12 hours ago Algo Grande Copper Core Testing Shows Mineralized Skarn is Denser and More Chargeable Than Host Rocks; Ground Gravity Survey to Begin at Adelita
Published on 10/07/2026 at 22:05, 13 hours 25 minutes ago Loar Holdings Inc. Announces Date and Time for Third Quarter 2026 Earnings and Conference Call
Published on 10/07/2026 at 17:00, 18 hours 30 minutes ago BlackBerry Radar Expands Asset Intelligence Platform with Dynamic Pairing
Published on 10/08/2026 at 11:13, 16 minutes ago InTiCa Systems SE completes segment change to Scale at the Frankfurt Stock Exchange effective October 14, 2026
Published on 10/08/2026 at 11:00, 30 minutes ago ABB Ltd: ABB share buybacks - October 1, 2026 - October 7, 2026
Published on 10/08/2026 at 10:44, 46 minutes ago Stable First-Half Performance in 2026 – Operating Platform Strengthened for Further Growth
Published on 10/08/2026 at 10:40, 49 minutes ago Avalara Helps Global Businesses Move Faster as Tax and Compliance Complexity Accelerates
Published on 10/08/2026 at 10:20, 1 hour 9 minutes ago Verity Names Anders Martens Chief Executive Officer
Published on 10/07/2026 at 20:15, 15 hours 14 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/07/2026 at 20:15, 15 hours 15 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/07/2026 at 20:15, 15 hours 15 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES SEPTEMBRE 2026
Published on 10/07/2026 at 20:15, 15 hours 15 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES SEPTEMBRE 2026
Published on 10/07/2026 at 18:19, 17 hours 10 minutes ago Outstanding shares and voting rights statement at 30 September 2026
